MCPHS University

American Foundation for Suicide Prevention Welcomes 2024 National Board Members

Retrieved on: 
Wednesday, January 10, 2024

NEW YORK, Jan. 10, 2024 /PRNewswire/ -- The American Foundation for Suicide Prevention (AFSP), a leading suicide prevention organization, is pleased to announce its 2024 National Board of Directors.

Key Points: 
  • NEW YORK, Jan. 10, 2024 /PRNewswire/ -- The American Foundation for Suicide Prevention (AFSP), a leading suicide prevention organization, is pleased to announce its 2024 National Board of Directors.
  • Board members oversee the organization's efforts to empower the public through suicide prevention research, education, support and advocacy.
  • It's through the leadership and dedication of those who serve on the National Board that AFSP will advance suicide prevention in our country," said AFSP Chief Executive Officer Robert Gebbia .
  • The American Foundation for Suicide Prevention is dedicated to saving lives and bringing hope to those affected by suicide, including those who have experienced a loss .

Zydus appoints Mr. Punit Patel as President and CEO to lead its business operations in North America

Retrieved on: 
Monday, October 16, 2023

AHMEDABAD, India, Oct. 16, 2023 /PRNewswire/ -- Zydus Lifesciences Limited (including its subsidiaries/affiliates hereafter referred to as 'Zydus') a discovery-driven, global lifesciences company announced the appointment of Mr. Punit Patel as President and Chief Executive Officer, Americas.

Key Points: 
  • AHMEDABAD, India, Oct. 16, 2023 /PRNewswire/ -- Zydus Lifesciences Limited (including its subsidiaries/affiliates hereafter referred to as 'Zydus') a discovery-driven, global lifesciences company announced the appointment of Mr. Punit Patel as President and Chief Executive Officer, Americas.
  • He will be responsible for the business operations of all Zydus entities in North America which include generics, injectables and specialty business, rare and orphan disease portfolio and also future forays into novel therapeutics.
  • Prior to his joining Zydus, Mr. Punit Patel was the President of Red Oak Sourcing, helming a multi-billion-dollar generic portfolio.
  • "We look forward to Punit joining our organisation," said Dr. Sharvil Patel, Managing Director, Zydus Lifesciences Ltd., "As a seasoned and successful business leader, Punit brings rich and varied experience in healthcare and pharmaceuticals to lead Zydus into the future.

DiaMedica Therapeutics Announces the Appointment of Biopharma Veteran Tanya Lewis to Its Board of Directors

Retrieved on: 
Monday, March 6, 2023

DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for neurological disorders and kidney diseases, announced today the appointment of Tanya Lewis to its board of directors effective March 1, 2023.

Key Points: 
  • DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for neurological disorders and kidney diseases, announced today the appointment of Tanya Lewis to its board of directors effective March 1, 2023.
  • Ms. Lewis, a recognized leader in the biopharma industry, brings over 25 years of experience in drug development, having played a key role in the approval of multiple new drugs.
  • Ms. Lewis joined the executive management team at Replimune in May 2021 after serving on Replimune’s board of directors since November 2020.
  • “Tanya is a respected and highly accomplished pharmaceutical industry executive with experience in global drug development and regulatory affairs.

CfPIE Introduces New Course on Ethics in Medical Research

Retrieved on: 
Wednesday, December 14, 2022

Ethics in Research — Values for Responsible Conduct of Research will provide participants with the necessary concepts and vocabulary to engage with ethical challenges along with the skills to identify and address moral dilemmas.

Key Points: 
  • Ethics in Research — Values for Responsible Conduct of Research will provide participants with the necessary concepts and vocabulary to engage with ethical challenges along with the skills to identify and address moral dilemmas.
  • "Given the ever-evolving complexity concerning Ethics in Research, CfPIE is excited to offer our first course devoted to this topic and presented by one of the most respected experts on the subject," explains Mark Mazzie, CfPIE founder and CEO.
  • Ethics in Research - Values for Responsible Conduct of Research will be hosted online from 9:00 a.m. to 5:00 p.m. CST on Jan. 30 and 31.
  • The Center for Professional Innovation and Education (CfPIE) is the global leader in life sciences training, providing specialized courses for pharma/biotech, medical device, and skin/cosmetics topics.

Robert Gatchell Joins Remark Holdings, Inc. as Senior Executive Vice President of Operations

Retrieved on: 
Tuesday, June 28, 2022

LAS VEGAS, June 28, 2022 /PRNewswire/ -- Remark Holdings, Inc. (NASDAQ: MARK), a diversified global technology company with leading artificial intelligence ("AI") solutions and digital media properties, today announced that Robert Gatchell would be joining Remark as Senior Executive Vice President of Operations, where he will provide leadership for the emerging security platform for Remark and help define strategic missions for the company in the realm of emergency preparedness and risk-based solutions. The company's primary focus will be on emerging technology and cyber security, and it will offer its clients a broad range of services to increase their resiliency and better prepare them to manage any potential business interruption.  

Key Points: 
  • "As a former customer, Robert Gatchell joining the Remark operating team is the best endorsement for our AI smart safety platform," says Kai-Shing Tao, Chief Executive Officer of Remark Holdings.
  • The company's corporate headquarters and U.S. operations are based in Las Vegas, Nevada, and it also maintains operations in London, England, and Shanghai, China.
  • Risk Factors in Remark Holdings' Annual Report on Form 10-K and Remark Holdings' other filings with the SEC.
  • Any forward-looking statements reflect Remark Holdings' current views concerning future events, are based on assumptions, and are subject to risks and uncertainties.

Gabrielle Pesaturo, PMHNP-BC Joins South County Psychiatry's Massachusetts Practice

Retrieved on: 
Tuesday, May 24, 2022

NORTH KINGTOWN, R.I., May 24, 2022 /PRNewswire-PRWeb/ -- Gabrielle Pesaturo, a Board-Certified Psychiatric Mental Health Nurse Practitioner, has joined South County Psychiatry, which recently expanded its practice area to serve patients in Massachusetts.

Key Points: 
  • Gabrielle Pesaturo, a Board-Certified Psychiatric Mental Health Nurse Practitioner, has joined South County Psychiatry, which recently expanded its practice area to serve patients in Massachusetts.
  • NORTH KINGTOWN, R.I., May 24, 2022 /PRNewswire-PRWeb/ -- Gabrielle Pesaturo, a Board-Certified Psychiatric Mental Health Nurse Practitioner, has joined South County Psychiatry , which recently expanded its practice area to serve patients in Massachusetts.
  • "We couldn't be prouder to welcome Gabrielle to our team," said Dr. Anthony Gallo, psychiatrist, and founder of South County Psychiatry.
  • We are thrilled that she has chosen South County Psychiatry as the practice that best matches her aims as a mental health care practitioner."

PDS Biotechnology Appoints Seasoned Business Development Executive Sanjay Zaveri as Senior Vice President, Business Development

Retrieved on: 
Wednesday, May 18, 2022

As PDS Biotechs Senior Vice President of Business Development, he is responsible for business strategy, and managing the Companys potential licensing and partnering opportunities in support of PDS Biotechs pipeline.

Key Points: 
  • As PDS Biotechs Senior Vice President of Business Development, he is responsible for business strategy, and managing the Companys potential licensing and partnering opportunities in support of PDS Biotechs pipeline.
  • Prior to joining PDS Biotech he held the position of Head of Business Development and Corporate Strategy at Strongbridge Biopharma, leading their business development, licensing and partnership strategy prior to its acquisition by Xeris Pharmaceuticals.
  • He brings a great depth of experience successfully conducting business development in the life science industry, said PDS Biotech Chief Executive Officer, Frank Bedu-Addo.
  • PDS Biotechs 2019 Inducement Plan, as amended, provides for the granting of equity awards to new employees of PDS Biotech.

Pear Therapeutics to Present at 2022 Rx and Illicit Drug Summit

Retrieved on: 
Monday, April 18, 2022

Pear Therapeutics, Inc. (Nasdaq: PEAR), the leader in developing and commercializing software-based medicines called prescription digital therapeutics (PDTs), today announced the company will host an educational Vision Session at the Rx and Illicit Drug Summit (Rx Summit), April 18-21 in Atlanta, GA.

Key Points: 
  • Pear Therapeutics, Inc. (Nasdaq: PEAR), the leader in developing and commercializing software-based medicines called prescription digital therapeutics (PDTs), today announced the company will host an educational Vision Session at the Rx and Illicit Drug Summit (Rx Summit), April 18-21 in Atlanta, GA.
  • The Rx Summit is the largest annual gathering for global stakeholders to address the opioid and addiction epidemic and share best practices and strategies for prevention, treatment, and recovery.
  • To learn more about the Session, which will take place on Tuesday, April 19 at 8:00 ET in International Ballroom A-D, please visit www.rx-summit.com/agenda .
  • Pear Therapeutics, Inc., which is traded on Nasdaq as PEAR, is the parent company of Pear Therapeutics (US), Inc. Pear is the leader in developing and commercializing software-based medicines, called prescription digital therapeutics (PDTs).

Retia Medical Announces James Ferreira as VP of Sales

Retrieved on: 
Wednesday, February 2, 2022

James' responsibilities include sales team leadership, accelerating adoption of Retia's monitors by leading academic medical centers and hospital integrated delivery networks, and contributing to the company's overall marketing and business strategies.

Key Points: 
  • James' responsibilities include sales team leadership, accelerating adoption of Retia's monitors by leading academic medical centers and hospital integrated delivery networks, and contributing to the company's overall marketing and business strategies.
  • James brings over 16 years of medical device sales and sales leadership experience to Retia.
  • Prior to joining Retia, he held positions of increasing sales leadership responsibility at Rockwell Medical, Cheetah Medical, Baxter/Gambro and GlaxoSmithKline.
  • Retia Medical is proud to positively impact patient care in the U.S. and internationally as more hospitals continue to incorporate the Argos Cardiac Output Monitor into their standard of care.

Bit.bio Appoints Accomplished Biotechnology Executive and Drug Developer Kathryn Corzo as Chief Operating Officer

Retrieved on: 
Wednesday, November 17, 2021

Cell coding company bit.bio today announces the key appointment of Kathryn Corzo as Chief Operating Officer.

Key Points: 
  • Cell coding company bit.bio today announces the key appointment of Kathryn Corzo as Chief Operating Officer.
  • View the full release here: https://www.businesswire.com/news/home/20211117005057/en/
    Corzo is a highly regarded biotechnology executive with extensive experience in early and late drug development across multiple indications and platforms.
  • Previously, Corzo was Sanofi Genzymes Vice President R&D Myeloma Head where she led global registration programs to drug approvals in the US, EU and Japan.
  • Accomplished biotechnology executive and drug developer who has served in senior leadership roles for several companies.